Business Context and Reporting Period
Company: Biorestorative Therapies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 19, 2012
Event: Regulation FD Disclosure regarding the preparation of presentation materials intended for use at the Marcum Microcap Conference on June 20, 2012, and other investor communications.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of presentation materials and does not contain financial statements or specific financial data.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing is procedural, noting the creation of summary presentation materials for upcoming investor meetings.
Guidance, Outlook, and Risks
- Management Commentary: The presentation materials are summary information and should be considered in the context of the Company's other SEC filings and public announcements.
- Forward-Looking Disclaimers: The Company specifically disclaims any obligation to update the presentation materials to reflect events or circumstances occurring after the date of this report.
- Legal Status: The information is "furnished" under Item 7.01 and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. It shall not be incorporated by reference into other registration statements unless expressly stated.
Key Facts for Investor Verification
- Verify the content of the presentation materials (Exhibit 99.1) posted on the Company's website (http://www.biorestorative.com) for 90 days following the filing date.
- Confirm that the summary information in the presentation materials aligns with the Company's most recent audited financial statements and other public disclosures.
- Note that the presentation materials are not legally "filed" and do not carry the same liability protections as formal SEC filings.